A Prognostic Model Based on POCUS at ICU Admission in Critically Ill Patients With Sepsis

Sponsor
Tribhuvan University Teaching Hospital, Institute Of Medicine. (Other)
Overall Status
Recruiting
CT.gov ID
NCT06082154
Collaborator
(none)
186
1
12.2
15.3

Study Details

Study Description

Brief Summary

Sepsis is responsible for one in three patient deaths. Understanding the severity of the disease, directing medications, prognosticating, and communicating with family members depend on the ability to predict outcomes in a patient presenting with sepsis in the ICU. The outcome of mortality reflects the caliber of ICU treatment. This is a prospective observational study that will include all patients diagnosed with sepsis for point-of-care ultrasonography within 24 hours of admission to the ICU from April 26, 2023, to March 30, 2024, and create a model that will predict 28 day outcome in these patients.

Condition or Disease Intervention/Treatment Phase
  • Device: ultrasound

Study Design

Study Type:
Observational
Anticipated Enrollment :
186 participants
Observational Model:
Other
Time Perspective:
Prospective
Official Title:
A Prognostic Model Based on POCUS at ICU Admission in Critically Ill Patients With Sepsis
Actual Study Start Date :
Apr 26, 2023
Anticipated Primary Completion Date :
Mar 30, 2024
Anticipated Study Completion Date :
Apr 30, 2024

Outcome Measures

Primary Outcome Measures

  1. 28 day status alive or dead [28 days]

    patient will be followed for 28 days from day of icu admission to find out their status being alive or dead

Eligibility Criteria

Criteria

Ages Eligible for Study:
16 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age >=16 yrs within 24 hour of ICU admission diagnosed as Sepsis as per Sepsis 3
Exclusion Criteria:
  • USG cannot be done within 24 hour of admission to icu If USG cannot be done for 2 parameters who does not give consent Withdrawal of active life support Do not intubate(DNI) or do not resuscitate(DNR) order at admission

Contacts and Locations

Locations

Site City State Country Postal Code
1 Ashmita Paudel Kathmandu Bagmati Nepal 1524

Sponsors and Collaborators

  • Tribhuvan University Teaching Hospital, Institute Of Medicine.

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ashmita Paudel, DM resident, Tribhuvan University Teaching Hospital, Institute Of Medicine.
ClinicalTrials.gov Identifier:
NCT06082154
Other Study ID Numbers:
  • 506(6-11)E2
First Posted:
Oct 13, 2023
Last Update Posted:
Oct 13, 2023
Last Verified:
Oct 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 13, 2023